Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease dermatitis, atopic
Symptom C0033774|pruritus
Sentences 34
PubMedID- 25688708 Background: oclacitinib is safe and effective for treating dogs with pruritus associated with allergic and atopic dermatitis, based on randomized clinical trials of up to 4 months duration.
PubMedID- 24909192 Animals: thirty client-owned dogs with symmetrical pedal pruritus due to canine atopic dermatitis.
PubMedID- 24112588 The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
PubMedID- 23829933 In this study, oclacitinib provided rapid, effective and safe control of pruritus associated with allergic dermatitis, with owners and veterinarians noting substantial improvements in pruritus and dermatitis vas scores.
PubMedID- 22315629 Non allergic factors such as skin dryness are involved in the development of pruritus associated with atopic dermatitis.
PubMedID- 25109820 Background: oral glucocorticoids are widely used to reduce pruritus and dermatitis associated with allergic dermatitis.
PubMedID- 23551368 Better management of pruritus in atopic dermatitis is an important goal and necessitates the development of novel targeted treatments as well as efficient use of current therapies.
PubMedID- 26280141 pruritus sometimes occurs with atopic dermatitis, pityriasis rosea, erythema infectiosum, molluscum contagiosum, and tinea infection.
PubMedID- 23959702 Cetirizine is a piperazine-derived second-generation antihistaminic drug recommended for treatment of pruritus associated with atopic dermatitis.
PubMedID- 25421804 pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey.
PubMedID- 23551371 We focus on pruritus associated with atopic dermatitis, herpes zoster, chronic urticaria, burns, and postoperative contexts where the evidence for cam approaches is promising.
PubMedID- 20628042 Topical corticosteroids reduce the inflammation and pruritus associated with atopic dermatitis and are available in several formulations and strengths.
PubMedID- 22773026 The goal of this study was to perform a meta-analysis on randomized controlled trials of topical therapies compared against their vehicles, and systemic therapies compared against their placebos, and to record how these therapies changed the magnitude of pruritus associated with atopic dermatitis.
PubMedID- 21818506 Objective: to investigate the efficacy, safety and tolerability of topical nalmefene (srd174), a long acting opioid antagonist for the management of pruritus associated with atopic dermatitis (ad).
PubMedID- 25873897 Several clinical trials have been conducted to evaluate the efficacy of h1r antagonists for the reduction of pruritus associated with atopic dermatitis, with limited evidence for efficacy (klein and clark, 1999; akdis et al., 2006; saeki et al., 2009).
PubMedID- 22207450 Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial.
PubMedID- 21664903 These results indicate that treatment with a h(4) receptor antagonist may be effective for amelioration of both skin inflammation and pruritus in patients with allergic dermatitis such as atopic dermatitis.
PubMedID- 24495176 Oclacitinib (apoquel®; zoetis inc., florham park, nj, usa) is a novel jak inhibitor that has recently been approved in the united states and european union for the control or treatment of pruritus associated with allergic dermatitis and the control or treatment of ad in dogs at least 12 months of age.
PubMedID- 24891679 Symptoms such as pruritus and worsening of atopic dermatitis do not always have a connection to ingested foods but patients may relate them to foods.
PubMedID- 24572110 Tslp, the key of pruritus in atopic dermatitis.
PubMedID- 25931325 Mediators of chronic pruritus in atopic dermatitis: getting the itch out.
PubMedID- 25524083 Serum gastrin-releasing peptide levels correlate with disease severity and pruritus in patients with atopic dermatitis.
PubMedID- 20480792 An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
PubMedID- 22681547 Background: oral triamcinolone (t) and methylprednisolone (m) have been recommended at various dosages for the control of pruritus associated with feline allergic dermatitis.
PubMedID- 23181126 For example, topical application of naltrexone inhibits pruritus in patients with atopic dermatitis (19).
PubMedID- 24441098 Serum autotaxin levels correlate with pruritus in patients with atopic dermatitis.
PubMedID- 23353988 Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis.
PubMedID- 24581322 Oclacitinib is a novel janus kinase inhibitor, recently approved in the usa and eu, for the control/treatment of pruritus associated with allergic dermatitis and the control/treatment of ad in dogs.
PubMedID- 23638997 Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis.
PubMedID- 25384221 Assessment of pruritus in patients with psoriasis and atopic dermatitis: subjective and objective tools.
PubMedID- 21527032 Eczema is a chronic relapsing atopic dermatitis (ad) associated with pruritus, sleep disturbance and poor quality of life of the patient.
PubMedID- 22747704 Case report of atopic dermatitis with refractory pruritus markedly improved with the novel use of clonidine and trimeprazine.
PubMedID- 24009842 Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin.
PubMedID- 25316126 Treatment with anti-5-ht receptors diminish the severity of contact allergy in experimental animals, an effect mediated by mast cells; while an agonist reduces the stress level and relieves pruritus in patients with atopic dermatitis.

Page: 1